Здоровье
Препарат GSK от гонореи достиг главной цели на поздней стадии испытаний
British drugmaker GSK said its oral drug to treat gonorrhoea has achieved a key goal of staying ahead of existing combination drugs in late-stage trials.
Цены на новые лекарства в США вырастут на 35% в 2023 году
Pharmaceutical companies last year launched new drugs in the U.S. at prices 35% higher than in 2022, partly reflecting the industry’s use of expensive treatments
Регулятор ЕС по лекарственным средствам поддерживает препарат от БАС от Biogen
The European medicines regulator on Friday recommended granting Biogen’s registration certificate to a drug for the deadly and progressive neurodegenerative disease known as amyotrophic lateral
Южнокорейские больницы продлевают рабочее время, чтобы справиться с протестом врачей
South Korea’s public hospitals will extend their working hours while expanding the use of telemedicine to ease growing pressure on health services following a mass
United Therapeutics начинает судебный процесс с FDA по поводу заявки на лекарство конкурента Liquidia
United Therapeutics said Wednesday it has filed a lawsuit with the U.S. Food and Drug Administration, alleging that proper procedures were not followed to allow
Инъекционный препарат от ВИЧ от GSK более перспективен
British drugmaker GSK said Wednesday that its long-acting injectable HIV therapy showed promising results in maintaining a suppressed viral load compared with daily oral treatment,
Индийские фармацевтические компании разрабатывают версии Wegovy
Indian drug companies have started developing their own versions of Novo Nordisk’s Wegovy. With some analysts predicting that the weight loss market will reach $100
Более половины мира сталкивается с высоким риском заражения корью
More than half of the world’s countries will be at high or very high risk of measles outbreaks by the end of the year unless
Препарат Johnson & Johnson от рака крови получил одобрение FDA США
The US Food and Drug Administration has approved Johnson & Johnson’s biweekly dose of Tecvayli blood cancer therapy. The approval allows the therapy to be
Южнокорейские врачи-стажеры бастуют против квот в медицинских школах
More than 1,600 trainee doctors at South Korea’s biggest hospitals went on strike Tuesday to protest a government plan to admit more students to medical